Abstract
Epidermal growth factor receptor (EGF-R) was studied in Dunning prostatic cancer models using competitive bindings assays and solution hybridization assay. EGF-R-binding capacity and mRNA were demonstrated in a hormone-sensitive R3327 prostatic tumor from both control and castrated animals while no such activity was found in the hormone-independent AT-1 tumors. Castration induced no quantitative changes in the EGF-R. Estrogen treatment induced a significant reduction of the binding capacity of EGF-R and its mRNA. It was concluded that EGF-R is present in the androgen-sensitive Dunning prostatic tumor models (R3327), but that the androgen-insensitive, undifferentiated AT-1 tumor lacks EGF-R expression. Endocrine treatment has no significant effect on the EGF-R in these tumor models.
Similar content being viewed by others
References
Benraad TJ, Foekens JA (1990) Hydroxyapatite assay to measure epidermal growth factor receptor in human primary breast tumors. Ann Clin Biochem 27:272
Chabot J-G, St-Arnaud R, Walker P, Pelletier G (1986) Distribution of epidermal growth factor receptors in the ovary. Mol Cell Endocrinol 44:99
Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294
Davies P, Eaton CL (1989) Binding of epidermal growth factor by human normal, hypertrophic and carcinomatous prostate. Prostate 14:123
Davies P, Eaton CL (1991) Regulation of prostate growth J Endocrinol 131:5
Derynck R, Goeddel DV, Ullrich A, Gutterman JU, Williams RD, Bringman TS, Berger WH (1987) Synthesis of mRNA's for transforming growth factors and the epidermal growth factor receptor for human tumors. Cancer Res 47:707
Downward J, Parker P, Waterfield RA (1984) Autophosphorylation sites on the epidermal growth factor receptor. Nature 311:483
Durnam DM, Palmiter RD (1983) A practical approach for quantitating specific mRNAs by solution hybridization. Anal Biochem 131:385
Eaton CL, Davies P, Phillips MEA (1988) Growth factor involvement and oncogene expression in prostatic tumours. J Steroid Biochem 30:341
Eaton CL, Davies P, Harper M, France T, Rushmere N, Griffiths K (1991) Steroids and the prostate. J Steroid Biochem Mol Biol 40:175
Ekberg S, Carlsson L, Carlsson B, Billig H, Jansson J-O (1989) Plasma growth hormone pattern regulates epidermal growth factor (EGF) receptor messenger ribonucleic acid levels and EGF binding in the rat liver. Endocrinology 125:2158
Fiorelli G, DeBellis A, Longo A, Pioli P, Costantini A, Giannini S, Forti G, Serio M (1991) Growth factors in the human prostate. J Steroid Biochem Mol Biol 40:199
Habib FK, Maddy SQ (1987) Are epidermal growth factor receptors present in the human prostate. In: Peeters H (ed) Protides of the biological fluids. Pergamon Press, p 315
Habib FK, Chisholm GD (1991) The role of growth factors in the human prostate. Scand J Urol Nephrol 138 [Suppl]:53
Huggins C, Stevens RE Jr, Hodges CV (1941) Studies on prostatic cancer II. The effects of castration on advanced carcinoma of the prostate. Arch Surg 43:209
Isaacs JT (1987) Development and characterization of the available model systems for the study of the prostatic cancer. In: Coffey DS, Bruchovsky N, Gardner WH, Resnik MJ, Kerr JP (eds) Current concepts and approaches to the study of prostate cancer. Liss, New York, p 513
Klijn JGM, Berns PMJJ, Schmitz PIM, Foekens JA (1992) The clinical significance of epidermal growth factor receptor (EGFR) in human breast cancer: a review on 5232 patients. Endocr Rev 13:3
Landström M (1992) Endocrine treatment of prostatic adenocarcinoma. An experimental study in the rat. Umeå University Medical Dissertations, New Series No 346, Umeå, Sweden
Landström M, Bergh A, Tomic R, Damber J-E (1990) Estrogen treatment combined with castration inhibits tumor growth more effectively than castration alone in the dunning R 3327 rat prostatic adenocarcinoma. Prostate 17:57
Landström M, Damber J-E, Bergh A, Tomic R (1992) Doseresponse study of the effects of oestrogens on tumour growth and morphology in the Dunning R3327 prostatic adenocarcinoma. J Cancer Res Clin Oncol 118:30
Liang S-G, Taketani Y, Mizuno M (1990) Estradiol stimulates the binding of epidermal growth factor in cultured rat granulosa cells. Endocrinol Jpn 37:893
Liu A, Davis RJ, Flores C, Menon M, Seethalakshmi L (1992) Epidermal growth factor: receptor binding and effects on the sex accessory organs of sexually mature male mice. J Urol 148:427
Lubrano C, Petrangeli E, Catizone A, Santonati A, Concolino G, Rombola N, Frati L, DiSilverio F, Sciarra F (1989) Epidermal growth factor binding and steroid receptor content in human benign prostatic hyperplasia. J Steroid Biochem 34:499
MacDonald A, Chisholm GD, Habib FK (1990) Production and response of a human prostatic cancer line to transforming growth factor-like molecules. Br J Cancer 62:579
MacDonald A, Habib FK (1992) Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines. Br J Cancer 65:177
Maddy SQ, Chisholm GD, Busuttil A, Habib FK (1989) Epidermal growth factor receptors in human prostate cancer: correlation with histological differentiation of the tumor. Br J Cancer 60:41
Matuo Y, McKeehan WL, Yan GC, Nikolaropoulos S, Adams PS, Fukabori Y, Yamanaka H, Gaudreau J (1992) Potential role of HBGF (FGF) and TFG-α on prostate growth. Adv Exp Med Biol 324:107
Maygarden SJ, Strom S, Ware JL (1992) Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia. Arch Pathol Lab Med 116:269
Melton DA, Krieg PA, Rebagliati MR, Maniatis T, Zinn K, Green MR (1984) Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res 12:7035
Morris GL, Dodd JG (1990) Epidermal growth factor receptor mRNA levels in human prostatic tumors and cell lines. J Urol 143:1272
Neal DE, Bennett MK, Hall RR, Marsh C, Abel PD, Sainsbury JRC, Harris AL (1985) Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumors. Lancet I:366
Peeling WB, Griffiths K (1986) Endocrine treatment of prostatic cancers. In: Blandy JP, Lytton B (eds) The prostate. Butterworths, London, p 188
Sambrook J, Fritsch EF and Maniatis T (1989) Molecular cloning, a laboratory manual. Cold Spring Harbor Press, New York
Schuurmans ALG, Bolt J, Mulder E (1988) Androgens stimulate both growth rate and epidermal growth factor receptor activity of the human prostate tumour cell line LNCaP. Prostate 12:55
St-Arnaud R, Poyet P, Walker P, Labrie F (1989) Androgens modulate epidermal growth factor receptor levels in the rat ventral prostate. Mol Cell Endocr 56:21
Thompson TC (1990) Growth factors and oncogenes in prostate cancer. Cancer Cells 2:345
Tillotson JK, Rose DP (1991) Endogenous secretion of epidermal growth factor peptides stimulates growth of DU145 prostate cancer cells. Cancer Lett 60:109
Traish AM, Wotiz HH (1987) Prostatic epidermal growth factor receptors and their regulation by androgens. Endocrinology 121:1461
Turkes AO, Peeling WB, Griffiths K (1987) Treatment of patients with advanced cancer of the prostate: phase III trial, Zoladex against castration. A study by the British Prostate Group. J Steroid Biochem 27:543
Ullrich A, coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD, Seeburg PH (1984) Human epidermal growth factor receptor cDNA sequence and abberant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309: 418
Ware JL (1993) Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer. Cancer Metastasis Rev 12:287
Waterfield MD, Mayers ELV, Stroobant P, Bennett PLP, Young S, Goodfellow PN, Banting GS, Ozanne B (1982) An antibody to the human epidermal growth factor receptor. J Cell Biochem 20:149
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Damber, J.E., Bergh, A., Assarsson, B. et al. Epidermal growth factor receptor content in rat prostatic adenocarcinoma: effects of endocrine treatment. Urol Res 23, 119–125 (1995). https://doi.org/10.1007/BF00307942
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00307942